Importantly, the administration of glucagon is still capable of augmenting metabolic rate following an overnight fast (or state of energy deficit) in adult humans and experimental models of obesity (51, 60, 65–67). The gene discussed is GCG; the disease is obesity due to melanocortin 4 receptor deficiency.